Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches
Language English Country England, Great Britain Media print-electronic
Document type Journal Article
PubMed
29414014
DOI
10.1016/j.jpba.2018.01.043
PII: S0731-7085(17)33134-5
Knihovny.cz E-resources
- Keywords
- Anti-doping analysis, Bioanalysis, Blood and urine microsamples, Oxycodone, Therapeutic drug monitoring, Volumetric absorptive microsampling,
- MeSH
- Chromatography, Liquid methods MeSH
- Doping in Sports methods MeSH
- Plasma chemistry MeSH
- Humans MeSH
- Miniaturization methods MeSH
- Urine chemistry MeSH
- Drug Monitoring methods MeSH
- Morphinans blood urine MeSH
- Specimen Handling methods MeSH
- Blood Specimen Collection MeSH
- Oxycodone blood urine MeSH
- Oxymorphone blood urine MeSH
- Tandem Mass Spectrometry methods MeSH
- Body Fluids chemistry MeSH
- Dried Blood Spot Testing methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Morphinans MeSH
- noroxycodone MeSH Browser
- Oxycodone MeSH
- Oxymorphone MeSH
Oxycodone is a widely prescribed, full agonist opioid analgesic. As such, it is used clinically to treat different kinds of painful conditions, with a relatively high potential for doping practices in athletes. In this paper, different classic and innovative miniaturised matrices from blood and urine have been studied and compared, to evaluate their relative merits and drawbacks within therapeutic drug monitoring (TDM) and to implement new protocols for anti-doping analysis. Plasma, dried blood spots (DBS) and dried plasma spots (DPS) have been studied for TDM purposes, while urine, dried urine spots (DUS) and volumetric absorptive microsamples (VAMS) from urine for anti-doping. These sampling techniques were coupled to an original bioanalytical method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the evaluation and monitoring of the levels of oxycodone and its major metabolites (noroxycodone and oxymorphone) in patients under pain management and in athletes. The method was validated according to international guidelines, with good results in terms of precision, extraction yield and accuracy for all considered micromatrices. Thus, the proposed sampling, pre-treatment and analysis are attractive strategies for oxycodone determination in human blood and urine, with advanced options for application to derived micromatrices. Microsampling procedures have significant advantages over classic biological matrices like simplified sampling, storage and processing, but also in terms of precision (<9.0% for DBS, <7.7% for DPS, <7.1% for DUS, <5.3% for VAMS) and accuracy (>73% for DBS, >78% for DPS, >74% for DUS, >78% for VAMS). As regards extraction yield, traditional and miniaturised sampling approaches are comparable (>67% for DBS, >74% for DPS, >75% for DUS, >75% for VAMS). All dried matrices have very low volumes, leading to a significant advantage in terms of analysis feasibility. On the other hand, this also leads to a corresponding decrease in the overall sensitivity.
Addiction Treatment Centre Local Health Service Cossato Biella Italy
Department for Life Quality Studies Alma Mater Studiorum University of Bologna Rimini Italy
Department of Medicine and Surgery Sciences Alma Mater Studiorum University of Bologna Bologna Italy
References provided by Crossref.org